Vijay H. Naringrekar;Rajesh Babulal Gandhi;Manisha M. Dali;Charles E. Dahlheim;Sunita Borsadia;Manoj Nerurkar
发明人:
Manisha M. Dali,Charles E. Dahlheim,Sunita Borsadia,Vijay H. Naringrekar,Rajesh Babulal Gandhi,Manoj Nerurkar
申请号：
US12086876
公开号：
US08476239B2
申请日:
2006.12.19
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.
